Aptima
Payments companies reported to CMS as associated with Aptima. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Aptima, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Aptima
These are the largest totals companies reported as associated with Aptima. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Darren Wheeler | Las Vegas, NV | Anatomic Pathology | $328,135.81 |
| Melissa Martinez Adorno | Nashua, NH | Obstetrics & Gynecology | $240,765.12 |
| Neha Deshpande | Plainsboro, NJ | Obstetrics & Gynecology | $194,645.42 |
| Kyle Bukowski | Orlando, FL | Obstetrics & Gynecology | $153,394.35 |
| Michael Ruma | Albuquerque, NM | Maternal & Fetal Medicine | $128,578.63 |
| Tonya Chaffee | San Francisco, CA | Pediatrics | $104,245.82 |
| Shruti Bala | Tucson, AZ | Obstetrics & Gynecology | $100,995.45 |
| Nealya Bell-Silva | Saint Louis, MO | Women'S Health (Nurse Practitioner) | $90,532.37 |
| Ada Stewart | Columbia, SC | Family Medicine | $80,736.35 |
| Jamie Shutter | Las Vegas, NV | Anatomic Pathology & Clinical Pathology | $57,263.58 |
Prescribed Aptima?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.